The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- RT @jan_nolta: Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation | Science Translational Medicine… Time ago 1 Day via Twitter for iPhone
- RT @PintailLimited: Discovery's 'First In Human' Calls Much-Needed Attention To Clinical Trials t.co/eIO25Wmaqu Time ago 1 Day via Twitter for iPhone
- RT @LiverNurseCA: The hidden disease that’s on the rise among middle-aged Americans t.co/erE6tpVe2v via @WSJ Time ago 6 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.